Ann Plast Reconstr Surg | Volume 4, Issue 5 | Mini Review | Open Access

Intralesional Bleomycin Sclerotherapy in Children with Lymphangiomas: A Review Article

Volkan Sarper Erikci^*

Department of Pediatric Surgery, Saglik Bilimleri University, Turkey

^*Correspondance to: Volkan Sarper Erikci 

Fulltext PDF

Abstract

Lymphatic system may give rise to lymphangioma and this entity is usually accepted as a benign tumor. The most common symptoms are tumescence and enhancive disfigurement. As a sclerosing agent, bleomycin has been used in the management of patients with these lesions with successful outcomes. In this review the subject is overviewed and a concise literature regarding the treatment options with special emphasis to intralesional bleomycin injection is given. This treatment option creates achievement of noteworthy results in most of the children with lymphangioma without major undesirable side effects.

Keywords:

Lymphangioma; Bleomycin; Intralesional; Sclerotherapy

Citation:

Erikci VS. Intralesional Bleomycin Sclerotherapy in Children with Lymphangiomas: A Review Article. Ann Plast Reconstr Surg. 2020;4(5):1069..